Logo image of CRH

CRH PLC (CRH) Stock Fundamental Analysis

NYSE:CRH - New York Stock Exchange, Inc. - IE0001827041 - Common Stock - Currency: USD

101.48  -1.04 (-1.01%)

Fundamental Rating

5

CRH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 11 industry peers in the Construction Materials industry. While CRH is still in line with the averages on profitability rating, there are concerns on its financial health. CRH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CRH had positive earnings in the past year.
CRH had a positive operating cash flow in the past year.
CRH had positive earnings in each of the past 5 years.
CRH had a positive operating cash flow in each of the past 5 years.
CRH Yearly Net Income VS EBIT VS OCF VS FCFCRH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1.2 Ratios

With a Return On Assets value of 6.90%, CRH is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
CRH has a Return On Equity (16.16%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 9.33%, CRH is in line with its industry, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
ROA 6.9%
ROE 16.16%
ROIC 9.33%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRH Yearly ROA, ROE, ROICCRH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of CRH (9.82%) is worse than 63.64% of its industry peers.
CRH's Profit Margin has improved in the last couple of years.
CRH has a worse Operating Margin (13.78%) than 63.64% of its industry peers.
In the last couple of years the Operating Margin of CRH has grown nicely.
CRH has a Gross Margin of 35.70%. This is amongst the best in the industry. CRH outperforms 81.82% of its industry peers.
CRH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.78%
PM (TTM) 9.82%
GM 35.71%
OM growth 3Y6.97%
OM growth 5Y6.8%
PM growth 3Y2.92%
PM growth 5Y9.98%
GM growth 3Y2%
GM growth 5Y1.6%
CRH Yearly Profit, Operating, Gross MarginsCRH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRH is still creating some value.
There is no outstanding debt for CRH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRH Yearly Shares OutstandingCRH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M
CRH Yearly Total Debt VS Total AssetsCRH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

2.2 Solvency

CRH has an Altman-Z score of 3.29. This indicates that CRH is financially healthy and has little risk of bankruptcy at the moment.
CRH has a Altman-Z score of 3.29. This is comparable to the rest of the industry: CRH outperforms 45.45% of its industry peers.
The Debt to FCF ratio of CRH is 5.90, which is a neutral value as it means it would take CRH, 5.90 years of fcf income to pay off all of its debts.
CRH has a Debt to FCF ratio (5.90) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.52 indicates that CRH is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, CRH is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 5.9
Altman-Z 3.29
ROIC/WACC1.25
WACC7.46%
CRH Yearly LT Debt VS Equity VS FCFCRH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

CRH has a Current Ratio of 1.37. This is a normal value and indicates that CRH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.37, CRH is doing worse than 63.64% of the companies in the same industry.
A Quick Ratio of 0.91 indicates that CRH may have some problems paying its short term obligations.
CRH's Quick ratio of 0.91 is on the low side compared to the rest of the industry. CRH is outperformed by 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.91
CRH Yearly Current Assets VS Current LiabilitesCRH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.16% over the past year.
Measured over the past years, CRH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.17% on average per year.
Looking at the last year, CRH shows a small growth in Revenue. The Revenue has grown by 1.78% in the last year.
Measured over the past years, CRH shows a small growth in Revenue. The Revenue has been growing by 4.80% on average per year.
EPS 1Y (TTM)16.16%
EPS 3Y14.89%
EPS 5Y14.17%
EPS Q2Q%-76.56%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y6.79%
Revenue growth 5Y4.8%
Sales Q2Q%-74.62%

3.2 Future

CRH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.43% yearly.
CRH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.16% yearly.
EPS Next Y18.8%
EPS Next 2Y15.51%
EPS Next 3Y11.65%
EPS Next 5Y12.43%
Revenue Next Year6.89%
Revenue Next 2Y6.07%
Revenue Next 3Y5.08%
Revenue Next 5Y6.16%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRH Yearly Revenue VS EstimatesCRH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10B 20B 30B 40B
CRH Yearly EPS VS EstimatesCRH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.63 indicates a rather expensive valuation of CRH.
CRH's Price/Earnings ratio is a bit cheaper when compared to the industry. CRH is cheaper than 72.73% of the companies in the same industry.
CRH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.98.
With a Price/Forward Earnings ratio of 16.52, CRH is valued correctly.
CRH's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRH is cheaper than 81.82% of the companies in the same industry.
CRH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.66.
Industry RankSector Rank
PE 19.63
Fwd PE 16.52
CRH Price Earnings VS Forward Price EarningsCRH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRH indicates a somewhat cheap valuation: CRH is cheaper than 72.73% of the companies listed in the same industry.
CRH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRH is cheaper than 81.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.95
EV/EBITDA 12.39
CRH Per share dataCRH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

CRH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.04
PEG (5Y)1.38
EPS Next 2Y15.51%
EPS Next 3Y11.65%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.44%, CRH has a reasonable but not impressive dividend return.
CRH's Dividend Yield is rather good when compared to the industry average which is at 5.69. CRH pays more dividend than 81.82% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.30, CRH is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.44%

5.2 History

On average, the dividend of CRH grows each year by 11.83%, which is quite nice.
CRH has paid a dividend for at least 10 years, which is a reliable track record.
CRH has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)11.83%
Div Incr Years7
Div Non Decr Years7
CRH Yearly Dividends per shareCRH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

CRH pays out 48.85% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of CRH is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP48.85%
EPS Next 2Y15.51%
EPS Next 3Y11.65%
CRH Yearly Income VS Free CF VS DividendCRH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
CRH Dividend Payout.CRH Dividend Payout, showing the Payout Ratio.CRH Dividend Payout.PayoutRetained Earnings

CRH PLC

NYSE:CRH (3/3/2025, 1:22:06 PM)

101.48

-1.04 (-1.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)N/A N/A
Inst Owners87.98%
Inst Owner Change-12.18%
Ins Owners0.11%
Ins Owner Change0%
Market Cap72.22B
Analysts83.48
Price Target117.6 (15.88%)
Short Float %1.8%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield 1.44%
Yearly Dividend1.31
Dividend Growth(5Y)11.83%
DP48.85%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.94%
Min EPS beat(2)-7.83%
Max EPS beat(2)-2.06%
EPS beat(4)2
Avg EPS beat(4)-1.94%
Min EPS beat(4)-7.83%
Max EPS beat(4)1.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.98%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-1.38%
Revenue beat(4)1
Avg Revenue beat(4)-2.18%
Min Revenue beat(4)-6.05%
Max Revenue beat(4)1.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.98%
PT rev (3m)3.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-128.57%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)-0.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 19.63
Fwd PE 16.52
P/S 2.03
P/FCF 29.95
P/OCF 14.48
P/B 3.34
P/tB 7.74
EV/EBITDA 12.39
EPS(TTM)5.17
EY5.09%
EPS(NY)6.14
Fwd EY6.05%
FCF(TTM)3.39
FCFY3.34%
OCF(TTM)7.01
OCFY6.91%
SpS49.98
BVpS30.36
TBVpS13.12
PEG (NY)1.04
PEG (5Y)1.38
Profitability
Industry RankSector Rank
ROA 6.9%
ROE 16.16%
ROCE 12.16%
ROIC 9.33%
ROICexc 10.32%
ROICexgc 15.54%
OM 13.78%
PM (TTM) 9.82%
GM 35.71%
FCFM 6.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y6.97%
OM growth 5Y6.8%
PM growth 3Y2.92%
PM growth 5Y9.98%
GM growth 3Y2%
GM growth 5Y1.6%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 5.9
Debt/EBITDA 1.68
Cap/Depr 143.38%
Cap/Sales 7.25%
Interest Coverage 8.18
Cash Conversion 74.46%
Profit Quality 69.04%
Current Ratio 1.37
Quick Ratio 0.91
Altman-Z 3.29
F-Score6
WACC7.46%
ROIC/WACC1.25
Cap/Depr(3y)117.73%
Cap/Depr(5y)100.01%
Cap/Sales(3y)5.73%
Cap/Sales(5y)5.23%
Profit Quality(3y)75.96%
Profit Quality(5y)118.22%
High Growth Momentum
Growth
EPS 1Y (TTM)16.16%
EPS 3Y14.89%
EPS 5Y14.17%
EPS Q2Q%-76.56%
EPS Next Y18.8%
EPS Next 2Y15.51%
EPS Next 3Y11.65%
EPS Next 5Y12.43%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y6.79%
Revenue growth 5Y4.8%
Sales Q2Q%-74.62%
Revenue Next Year6.89%
Revenue Next 2Y6.07%
Revenue Next 3Y5.08%
Revenue Next 5Y6.16%
EBIT growth 1Y9.69%
EBIT growth 3Y14.23%
EBIT growth 5Y11.93%
EBIT Next Year45.79%
EBIT Next 3Y17.55%
EBIT Next 5Y15.77%
FCF growth 1Y-24.66%
FCF growth 3Y-3.17%
FCF growth 5Y-0.78%
OCF growth 1Y-0.56%
OCF growth 3Y5.82%
OCF growth 5Y5.15%